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Edited by Jesus AvilaAbstract The 1045 bp full-length cDNA sequence of a new bee
venom component was obtained by rapid ampliﬁcation of cDNA
ends. The 672 bp coding sequence corresponds to a protein with a
signal peptide and multiple carbohydrate binding sites, and it was
named icarapin. It has the new consensus sequence N-[TS]-T-
S-[TV]-x-K-[VI](2)-[DN]-G-H-x-V-x-I-N-[ED]-T-x-Y-x-[DHK]-
x(2,6)- [STA]-[VLFI]-x-[KR]-V-R-[VLI]-[IV]-[DN]-V-x-P. At
least two transcript variants were found. Recombinant icarapin
was tested for recognition by IgE antibodies and gave a positive
dot blot with sera from 4 out of 5 bee venom allergic patients, all
beekeepers. Indirect immunoﬂuorescent staining localized the
protein in the cuticular lining of the venom duct.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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When honeybees sting they deliver the venom sac contents
into their victims. Most bee stings cause transient localized
non IgE-mediated reactions in man requiring only local symp-
tomatic treatment. In contrast, large local reactions, that aﬀect
approximately 15–20% of general population, expand from the
site of the sting, consist of extensive erythematous swelling sur-
rounding the sting site, and represent late-phase IgE-mediated
hypersensitivity. More serious systemic reactions occur in 0.4–
0.8% of the children and 3% of adults, particularly beekeepers.
They can be mild, manifesting as a generalized cutaneous re-
sponse, but generalized anaphylaxis may also occur and can
be life-threatening [1,2]. Six bee venom components are known
to cause allergic reactions in man: Api m 1 (phospholipase A2),
Api m 2 (hyaluronidase), Api m 3 (acid phosphatase), Api m 4
(melittin), Api m 6 and Api m 7 (CUB serine protease) [3].
With the recent ﬁnding of new bee venom components [4,5]
the question raised whether these proteins could also contrib-
ute to the adverse immunological reactions evoked by bee
venom.Abbreviations: EST, expressed sequence tag; HIRS, hyperimmune ra-
bbit serum; GSP, gene speciﬁc primer; GSP-fw, gene speciﬁc forward
primer; GSP-rv, gene speciﬁc reverse primer; RACE, rapid ampliﬁca-
tion of cDNA ends; UTR, untranslated region
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doi:10.1016/j.febslet.2006.08.005Here we tested the IgE reactivity against ‘‘new venom pro-
tein 2’’, found on 2-DE gels of bee venom and identiﬁed by
mass spectrometry [4]. Because of its low abundance in bee
venom we have chosen to provide suﬃcient amounts of the
protein for immunological testing by the recombinant technol-
ogy. As Mascot searching of the mass spectrometric data of
venom protein 2 matched only a partial nucleotide sequence
(expressed sequence tag, EST) of the honeybee brain [6], its
coding sequence needed to be completed by rapid ampliﬁca-
tion of cDNA ends (RACE). The authors proposed to name
this new venom protein ‘‘icarapin’’.2. Materials and methods
2.1. Patient sera
Sera of ﬁve patients from the University Hospital of Antwerp (An-
twerp, Belgium) with a compelling history of bee venom allergy (urti-
caria, angio-edema, bronchospasm, hypotension and/or shock)
documented by positive quantiﬁcation of bee venom speciﬁc IgE by
ImmunoCAP FEIA (Phadia AB) (respective values: 100, 12.7, 2.57,
1.17, 7.23 kUa/L for patients 1–5), skin test (ALK-Abello˜) and/or
basophil activation test [1], were analyzed. All patients were beekeep-
ers, except patient 4. Negative control sera were from non-responsive
stung control persons (IgE values <0.35 kUa/L and negative basophil
activation test).
2.2. Bee venom gland preparation
The venom glands of 320 Carniolan honeybees (Apis mellifera car-
nica) were dissected under anesthesia by chilling. Firstly, the whole
sting apparatus was removed from the abdomen and submerged in
RNALater (Ambion). Subsequently, the glands were separated from
the reservoir and collected all together in 100 ll new solution. Homog-
enization and mRNA isolation was done using the Micro-FastTrack
2.0 Kit (Invitrogen) following the protocol for fresh and frozen tissue.
After the yield was determined, the mRNA was stored in elution buﬀer
at 80 C until further use.
2.3. cDNA preparation and primer development
Venom gland cDNA was prepared using AMV reverse transcriptase
and the oligo dT primer from the cDNA Cycle Kit (Invitrogen)
according to the manufacturer’s instructions. Icarapin gene speciﬁc
primers (GSP) for rapid ampliﬁcation of cDNA ends (RACE; see fur-
ther) were developed inside the gene fragments encoding the two tryp-
tic peptides found in previous work [4]: GSP forward primer (GSP-fw)
5 0-TGGACACTGTTCTCGTCCTACCGTCCA-3 0 and GSP reverse
primer (GSP-rv) 5 0-ACGTGACAAAATGCCAGCCATCTGC-3 0.
2.4. 5 0-Rapid ampliﬁcation of cDNA ends (5 0-RACE) and 3 0-RACE
RACE ready cDNA was prepared following the protocol described
in the GeneRacer Kit (Invitrogen). Brieﬂy, 100 ng of bee venom
gland mRNA was treated with calf intestinal phosphatase and tobaccoblished by Elsevier B.V. All rights reserved.
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RNA oligo. This ligated mRNA was reverse transcribed using the
SuperScript III RT and the GeneRacer oligo dT primer to create
RACE-ready ﬁrst-strand cDNA with known priming sites at the 5 0-
and 3 0-ends. Generation of 5 0-RACE fragment was done by PCR,
using a combination of GeneRacer 5 0-primer and GSP-rv, whereas
the 3 0-ampliﬁcation needed a combination of GSP-fw and GeneR-
acer 3 0 primer. Both reactions were done in an Eppendorf Mastercy-
cler using a touchdown protocol.
2.5. Expression of icarapin in bacteria
The complete coding sequence (stop codon excluded) of icarapin was
ampliﬁed using the following primer set: 5 0-ATGAAGACCCTT-
GGCGTTCT-3 0 and 5 0-AGCAGTTAATACATCTCCTTGGTTC-3 0.
The resulting amplicon had the expected length and was subsequently
cloned in pBAD-TOPO-TA (Invitrogen) according to manufacturer’s
instructions. The retained clone was sequenced for conﬁrmation.
Recombinant His-tagged icarapin was puriﬁed from L-arabinose
stimulated cells on the ProBond Puriﬁcation System (Invitrogen) under
denaturing conditions as described in the manufacturer’s instruction
manual. The puriﬁed protein was dialysed overnight at 4 C with
Tris–buﬀer (pH 8.0) supplemented with 0.1% Triton X-100 and con-
centrated on Vivaspin 2 ml microconcentrators (cut-oﬀ: 10 kDa; Viva-
science Ltd.). An irrelevant recombinant Cryptosporidium parvum
surface protein CP15/60 expressed in the same pBAD-TOPO-TA vec-
tor [7] served as negative control.
2.6. Dot blot
Two lg recombinant icarapin was spotted on nitrocellulose mem-
brane, air-dried and was washed twice with deionized water before
incubating in milk diluent (Sigma) for 1 h at room temperature. Sub-
sequently, the membrane was immersed with diluted human serum
(1:4 in milk diluent) overnight at 4 C. Indirect staining of speciﬁcally
bound human IgE was performed in three steps: ﬁrst with a monoclo-
nal anti-human IgE antibody (1:1000, Sigma) for three hours at room
temperature, thereafter with a peroxidase conjugated rabbit anti-
mouse IgG (1:8000, Sigma) for one hour and ﬁnally by incubating in
the chemiluminescent substrate (SuperSignal West Dura Extended
Duration, Pierce) for 10 min. Blots were washed with Tris–buﬀered sal-
ine after each treatment. The chemiluminescent reaction was visualized
and analyzed with a Chemi Doc system (Bio-Rad).
2.7. Western blot
A puriﬁed recombinant icarapin sample was separated on a 12%
SDS–PAGE and blotted to polyvinyldene diﬂuoride membrane. Icara-
pin-speciﬁc IgE staining was done as described above (dot blot). Anti-
His (C-terminal) HRP antibodies (1:5000, Invitrogen) were used to
localize the His-tagged recombinant proteins after chemiluminescent
reaction. The same antibodies were also used in an immunostaining
with 3,3 0-diaminobenzidine tetrahydrochloride, permitting to localize
the His-tagged bands on adjacent Coomassie Brilliant Blue G-250
stained strips. These Coomassie stained strips were used for N-terminal
sequencing of individually cut out bands.
2.8. Nucleotide and amino acid sequencing
DNA sequencing was performed using an ABI Prism 377 automated
DNA sequencer (Perkin Elmer), using the ABI Prism BigDye V 3.1
Terminator Cycle Sequencing kit. N-terminal amino acid sequencing
of blotted Coomassie stained protein bands was carried out on a
476 A pulsed liquid sequenator with on-line detection of the PTH-ami-
no acids (Applied Biosystems).
2.9. Immunolocalization
A hyperimmune rabbit serum (HIRS) was developed against recom-
binant icarapin by repeated immunizations (Ethics Committee ﬁle
041126-10). Disturbing anti-Escherichia coli antibodies were absorbed
with bacterial lysates. Ten lm paraﬃn sections of pooled honeybee ve-
nom glands were made using a Microm HM360 microtome. Immuno-
staining was done in a humidiﬁed chamber by incubating gland
sections ﬁrst in primary antibodies (1:25 in Tris–buﬀered saline with
0.05% Tween-20 and 3% bovine serum albumin) overnight at 4 C,
thereafter in FITC-conjugated anti-rabbit IgG (1:150, Sigma) for
30 min at room temperature. Images were taken with a confocallaser-scanning microscope (MRC1024 UV, Bio-Rad). Excitation was
done with a Kr/Ar laser at 488 nm (dichroic ﬁlter UBHS, emission ﬁl-
ter: O G515). The speciﬁcity of the staining was evaluated by depleting
the anti-icarapin antibodies in a 4-h incubation step with aﬃnity puri-
ﬁed recombinant icarapin, prior to the overnight incubation.3. Results
3.1. Nucleotide sequence
5 0-Rapid ampliﬁcation of cDNA ends (5 0-RACE) using
gene-speciﬁc primers resulted in an amplicon of approximately
500 bp in size that was cloned in the pCR4 vector. Transfor-
mation to chemically competent TOP-10 E. coli yielded a large
number of transformants, nine of which were retained for fur-
ther analysis. The DNA sequences found were identical and
represented by the insert of clone 5.V4. 3 0-RACE resulted in
a fragment of approximately 850 bp and some minor rapidly
migrating bands. The 850 bp band was cut out and selectively
ampliﬁed again by PCR, and thereafter cloned and sequenced
as described above. These sequencing data were represented by
the insert of clone 3.A4. Subsequently, we ampliﬁed the com-
plete icarapin transcript from a venom gland cDNA prepara-
tion using primers designed, respectively, at the extreme 5 0-
and 3 0-ends of clone 5.V4 and clone 3.A4. This full-length
cDNA of icarapin is 1045 bp long and consists of a 5 0 untrans-
lated region (UTR) of 160 bp, a 672 bp coding sequence and a
3 0 UTR of 213 bp. Some remarkable sequence diﬀerences were
found when compared to the previously cloned 3 0RACE ends
(see further). We named this full-length cDNA transcript var-
iant 1 and deposited its nucleotide sequence to Genbank
(accession number DQ485318). It was demonstrated that the
icarapin gene has three introns located at the genome positions
6756463-6780887 (or in between transcript positions 224/225),
6781092-6795150 (428/429), and 6795279-6796248 (556/557) of
chromosome 1 in the honeybee genome assembly 3.08 (Supple-
mentary Fig. 1). Beside, the insert of clone 3.A4 was considered
to be a part of another transcript variant (variant 2; GenBank
accession number DQ485319) of icarapin, characterized by an
alternative splicing at the intron 2 end (genome positions
6781092-6795162) resulting in a transcript that is 12 bp
shorter. Both transcript variants showed to have one single
deletion mutation of 4 Ts in a 16-mer poly-T repeat when com-
pared to the honeybee genome assembly 3.08. As the deletion
mutation was situated in the 3 0 UTR there were no conse-
quences for the expressed gene products.3.2. Deduced amino acid sequence
The deduced amino acid sequences of transcript variant 1
represents a polypeptide of 223 amino acids (GenBank acc.
n ABF21077) and based on an in silico SigP-NN prediction
[8], a signal peptide cleavage site was identiﬁed between posi-
tion 19 and 20 (Supplementary Fig. 2). The mature protein
has multiple putative N- and O-linked glycosylation sites as
determined by NetOGlc 3.1 and NetNGLC 1.0 [9]. BLASTP
searching revealed a strong homology (BLAST score up to
63.9; E-value: 4e-9) with a series of mostly unknown insect
proteins (Genbank acc. n XP_975949, XP_966682,
EAA45242, ABF18040, EAL33820, AAQ09844, AAL48770,
NP_995688 and NP_723747). They all share a consensus
sequence of 41 (sometimes 37) residues: N-[TS]-T-S-[TV]-x-K-
[VI](2)-[DN]-G-H-x-V-x-I-N-[ED]-T-x-Y-x-[DHK]-x(2,6)-
Fig. 1. Alignment of the 41 (sometimes 37) residues of a consensus sequence found in a series of mostly unknown insect proteins, ﬂanked by their
start and stop positions. Species names on the left are followed by Genbank accession numbers and total length (in number of amino acids) of the
protein fragment (in parentheses). ‘‘’’ means that the residues in that column are identical in all sequences in the alignment; ‘‘:’’ means that conserved
substitutions have been observed; ‘‘Æ’’ means that semi-conserved substitutions are observed.
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represents any amino acid, the value in parentheses indicate
the number of residues and the letters between brackets repre-
sent only one of the given amino acids) (Fig. 1).
3.3. Expression of recombinant icarapin and testing of its IgE
reactivity
Expression of icarapin in the pBAD-TOPO prokaryotic vec-
tor gave a major His-tagged protein band of 32.2 kDa on SDS-
PAGE. After puriﬁcation on a nickel-chelating aﬃnity column
a number of thin, rapidly migrating His-tagged bands (be-
tween 17.7 and 25.7 kDa) accompanied this major band.
Four out of 5 patients with varying venom speciﬁc IgE titers
gave a positive dot blot against icarapin (Fig. 2; patient 1, 2, 3
and 5). Serum from non-responsive stung control persons
tested negative. Whole (native) bee venom (ALK-Abello˜) gave
the same ratio of IgE reactivity as icarapin (4 out of 5), but the
one patient that did not react was diﬀerent (here patient 5).
Dots with the irrelevant apicomplexan protein CP15/60 re-
mained uncolored (not shown). Westernblot analysis revealedFig. 2. IgE-speciﬁc staining of dot blots using sera from bee venom
allergic patients (all were beekeepers except patient 4) and non-
responsive stung control persons (neg. ctl.). In the blanco nitrocellulose
strips no serum was added. Protein spots were made with recombinant
icarapin, natural bee venom, a peroxidase conjugated immunoglobulin
(pos. ctl.) or with buﬀer only.that the IgE recognition of the preparation was not only
caused by the major 32.2 kDa His-tagged band, but also by
its companying His-tagged breakdown products (Fig. 3). N-
terminal amino acid sequencing of a Coomassie blue stained
band cut from the PVDF blot at the same height as the
32.2 kDa IgE reactive band (position determined by the anti-
His staining) revealed 7 consecutive residues of the enteroki-
nase recognition site that precedes icarapin in the (recombi-
nant) fusion protein.Fig. 3. Westernblots and Coomassie stained blots of aﬃnity chroma-
tography puriﬁed recombinant icarapin. IgE-speciﬁc staining was done
with chemiluminescent substrate using sera from a bee venom allergic
beekeeper (patient 1) and a non-responsive stung control person (neg.
ctl.). The recombinant icarapin was localized using an anti-His
monoclonal that was peroxidase conjugated and stained with the
chemiluminescent substrate and with 3,3 0-diaminobenzidine tetrahy-
drochloride (DAB), permitting to localize the His-tagged bands on the
adjacent Coomassie Brilliant Blue G-250 stained strips. The arrow
indicates the protein band that was cut out the blot and identiﬁed as
icarapin by sequencing.
Fig. 4. Immunolocalization of icarapin using a hyperimmune rabbit serum. (A) A strong ﬂuorescent area at the cuticular lining of venom duct was
seen, with some minor staining inside the secretory cells. (B) When the serum was depleted with aﬃnity puriﬁed recombinant icarapin the signal
disappeared completely. Scale is give in lm.
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Staining of bee venom gland sections with anti-icarapinHIRS
revealed strong ﬂuorescent area at the cuticular lining of the
venom duct, with some minor staining inside the secretory cells
(Fig. 4). When the HIRS was depleted with aﬃnity puriﬁed
recombinant icarapin the signal disappeared completely.4. Discussion
Icarapin was ﬁrst identiﬁed in a proteomic study of bee
venom that was obtained from manually stimulated bees [4],
leaving a trace of uncertainty about its origin: had this compo-
nent leaked from gland tissue by squeezing out the venom sac?
The ﬁnding in the present paper that it has a signal peptide,
typical for secreted proteins, and that it evokes an immune re-
sponse in some subjects after a bee sting, provides the required
conﬁrmation of its release during the normal sting action. In
addition, this new bee venom component was independently
found by another research group in reversed phase chromatog-
raphy fractionated bee venom [5]. However, its occurrence in
the cuticular lining of the venom duct is at the moment diﬃcult
to interpret: or icarapin penetrates from the venom into the
cuticular lining that surrounds the duct and the sac, or icarapin
is a component of this cuticular lining and leaks into the
venom lumen. The latter seems unlikely as icarapin lacks the
consensus sequences that are typical for cuticular proteins [10].
Sequencing data demonstrated that icarapin displays a pro-
tein heterogeneity that is at least partially due to alternative
splicing of a single transcript, an observation also made for
tropomyosins from the lobster Homarus americanus striated
muscles [11]. Tropomyosin is an important food allergen from
many other crustacean species (see the International Union of
Immunology Societies’ list of allergens at http://www.aller-
gen.org/List.htm). It was remarkable to ﬁnd homology with
a set of mostly unknown insect proteins, all sharing the same
consensus sequence of 37–41 residues. One of these homo-
logues is a putative salivary secreted mucin 3 from Aedes ae-
gypti, but as icarapin has no regions rich in proline,
threonine and serine residues occurring in clusters (in spite of
its high Pro, Thr, Ser content of 21%) and cysteine residuesare absent, it lacks some common features of mucins or mu-
cin-like proteins [12].
Because of the failure to assign to this new venom protein a
biological function, we proposed to name it icarapin, a junc-
tion of Icarus (Greek mythology) and Apis (genus of the hon-
eybee) and referring to one of its most striking characteristics
so far: its unstable nature. Indeed, it was previously described
that on a 2-DE gel of pure venom, the full-size protein is
accompanied by low molecular weight degraded forms [4]. A
similar picture was seen in the aﬃnity puriﬁed recombinant
samples of the present paper, although here the degradation
occurred in a more stepwise way.
The ﬁnding that 4 out of 5 patients with a compelling case
history of bee venom allergy developed an icarapin-speciﬁc
IgE-response suggests that it might concern a new bee venom
allergen. This IgE recognition should now be further validated.
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